Veterinary Therapeutics Market
Veterinary therapeutics Market Forecasts to 2032 – Global Analysis By Product (Veterinary Drugs, Veterinary Vaccines and Medicated Feed Additives), Animal Type, Route of Administration, Distribution Channel and By Geography
According to Stratistics MRC, the Global Veterinary Therapeutics Market is accounted for $58.8 billion in 2025 and is expected to reach $110.2 billion by 2032 growing at a CAGR of 9.4% during the forecast period. Veterinary therapeutics refers to the branch of veterinary medicine that focuses on diagnosing, treating, and managing animal diseases using pharmacological, immunological, and supportive therapies. It encompasses a wide range of interventions, including antibiotics, vaccines, antiparasitics, analgesics, and biologics tailored to various species. These therapeutic strategies aim to restore health, alleviate pain, prevent disease progression, and improve overall animal welfare. Veterinary therapeutics also plays a vital role in livestock productivity, zoonotic disease control, and public health.
According to the World Organization for Animal Health, foot and mouth disease affects 77.0% of the global livestock population.
Market Dynamics:
Driver:
Rising Pet Ownership & Human-Animal Bond
The surge in pet ownership and deepening human-animal bonds is significantly propelling the Veterinary therapeutics market. With pets increasingly seen as family, there's rising demand for advanced, personalized care, including preventive and chronic condition treatments. This emotional connection drives higher spending on wellness, innovative therapies, and diagnostics. Moreover, growing awareness of pet health fosters product development and veterinary service expansion, reinforcing the market’s trajectory toward robust growth and innovation across pharmaceuticals, biologics, and companion animal care segments.
Restraint:
High Cost of Advanced Veterinary therapeutics
The high cost of advanced Veterinary therapeutics poses a significant barrier to market growth, especially in developing regions where pet insurance is limited and affordability is a concern. These costly treatments often deter pet owners and livestock farmers from seeking timely care, leading to reduced adoption rates. The financial burden also discourages smaller clinics from stocking innovative therapies, ultimately hindering market expansion and access to cutting-edge veterinary solutions.
Opportunity:
Technological Advancements in Veterinary Medicine
Technological advancements in veterinary medicine are transforming the Veterinary therapeutics market by enhancing diagnostic precision, treatment efficacy, and personalized care. Innovations such as AI-driven diagnostics, telemedicine, and regenerative therapies are accelerating early disease detection and improving outcomes. The integration of smart devices and data analytics boosts real-time monitoring and decision-making. These developments not only increase clinical efficiency and reduce costs but also expand access to care, driving market growth and fostering continuous innovation in Veterinary therapeutics.
Threat:
Stringent Regulatory Approvals
Stringent regulatory approvals pose a significant hindrance to the Veterinary therapeutics market. Lengthy approval timelines, complex documentation, and rigorous safety and efficacy trials delay product launches and increase development costs. Smaller players often struggle to meet these demands, limiting innovation and market entry. These strict regulations, though essential for animal welfare, act as a bottleneck, restricting swift advancements and the availability of novel therapies across regions.
Covid-19 Impact
The COVID-19 pandemic had a mixed impact on the Veterinary therapeutics market. Initially, lockdowns and movement restrictions disrupted veterinary services, supply chains, and delayed non-urgent treatments. However, the crisis also heightened awareness of zoonotic diseases, emphasizing the need for robust animal health systems. Pet adoption surged during lockdowns, increasing demand for companion animal therapeutics. As the world adapted, telemedicine and home-care solutions gained traction, reshaping veterinary care delivery models.
The veterinary vaccines segment is expected to be the largest during the forecast period
The veterinary vaccines segment is expected to account for the largest market share during the forecast period because their preventive nature lowers treatment costs and supports sustainable animal health management. Technological advancements in vaccine development—such as recombinant and vector-based platforms—drive innovation across therapeutics. Additionally, vaccines contribute to public health by curbing zoonotic transmissions and ensuring safer food supplies. This growing segment not only complements therapeutic interventions but also accelerates market expansion through improved disease control.
The online stores segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the online stores segment is predicted to witness the highest growth rate as these platforms streamline product discovery for pet owners and livestock managers, improve affordability through competitive pricing, and enhance market penetration in remote areas. Additionally, e-commerce facilitates direct-to-consumer delivery, fostering convenience and compliance with veterinary care regimens. Their integration with AI-powered recommendations and subscription models is further optimizing therapeutic outcomes and driving sustained market growth.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising pet ownership and heightened awareness of animal health. Countries like India, China, and South Korea are investing in advanced treatments and preventive care, boosting demand for vaccines, diagnostics, and pharmaceuticals. Technological innovations and government initiatives are enhancing veterinary infrastructure, improving disease management, and supporting food security. This dynamic market is fostering economic development and elevating standards in animal welfare across the region.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to high spending on companion animal healthcare, and advanced veterinary infrastructure. The region benefits from a strong network of veterinary clinics, widespread insurance coverage, and early adoption of innovative treatments like biologics and precision diagnostics. Supportive government regulations and growing awareness about zoonotic disease control further boost the market. North America's technologically advanced ecosystem and emphasis on animal welfare continue to drive the demand for effective therapeutic solutions.
Key players in the market
Some of the key players profiled in the Veterinary therapeutics Market include Zoetis Inc., Elanco Animal Health Incorporated, Merck Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, IDEXX Laboratories, Inc., Phibro Animal Health Corporation, Norbrook Laboratories Ltd., Zydus Animal Health, Kindred Biosciences, Inc., Neogen Corporation, Bimeda Animal Health, Biogénesis Bago, Ourofino Saúde Animal and Kyoritsu Seiyaku Corporation.
Key Developments:
In June 2025, Infosys has entered into a strategic, long-term consulting partnership with Zoetis, the world’s leading animal health company, Under this deal, Infosys will support Zoetis by integrating advanced AI driven solutions, automation, and digital enhancements into their IT operations. The goal is to boost agility and streamline systems, enabling Zoetis to better serve veterinarians, livestock producers, and pet owners globally.
In April 2025, Elanco has entered into a strategic research partnership with WEDterinary LLC, to pursue groundbreaking therapies for chronic kidney disease (CKD) in cats and explore approaches for extending healthy lifespan in pets. The first phase of this collaboration involves pioneering targeted gene therapy specifically aimed at treating feline CKD, while also delving into emerging technologies in life-extension for companion animals.
Products Covered:
• Veterinary Drugs
• Veterinary Vaccines
• Medicated Feed Additives
Animal Types Covered:
• Companion Animals
• Livestock Animals
Routes of Administration Covered:
• Oral
• Parenteral
• Topical
• Aerosol
Distribution Channels Covered:
• Veterinary Hospitals & Clinics
• Feed Stores
• Pharmacies
• Online Stores
• Other Distribution Channels
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Veterinary therapeutics Market, By Product
5.1 Introduction
5.2 Veterinary Drugs
5.2.1 Anti-infectives
5.2.2 Anti-inflammatory
5.2.3 Parasiticides
5.3 Veterinary Vaccines
5.3.1 Inactivated
5.3.2 Live Attenuated
5.3.3 Recombinant
5.4 Medicated Feed Additives
5.4.1 Antimicrobials
5.4.2 Anticoccidials
5.4.3 Antiparasitics
6 Global Veterinary therapeutics Market, By Animal Type
6.1 Introduction
6.2 Companion Animals
6.2.1 Dogs
6.2.2 Horses
6.2.3 Cats
6.3 Livestock Animals
6.3.1 Cattle
6.3.2 Sheep & Goats
6.3.3 Poultry
6.3.4 Swine
7 Global Veterinary therapeutics Market, By Route of Administration
7.1 Introduction
7.2 Oral
7.3 Parenteral
7.4 Topical
7.5 Aerosol
8 Global Veterinary therapeutics Market, By Distribution Channel
8.1 Introduction
8.2 Veterinary Hospitals & Clinics
8.3 Feed Stores
8.4 Pharmacies
8.5 Online Stores
8.6 Other Distribution Channels
9 Global Veterinary therapeutics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Zoetis Inc.
11.2 Elanco Animal Health Incorporated
11.3 Merck Animal Health
11.4 Boehringer Ingelheim Animal Health
11.5 Ceva Santé Animale
11.6 Virbac
11.7 Vetoquinol S.A.
11.8 Dechra Pharmaceuticals PLC
11.9 IDEXX Laboratories, Inc.
11.10 Phibro Animal Health Corporation
11.11 Norbrook Laboratories Ltd.
11.12 Zydus Animal Health
11.13 Kindred Biosciences, Inc.
11.14 Neogen Corporation
11.15 Bimeda Animal Health
11.16 Biogénesis Bagó
11.17 Ourofino Saúde Animal
11.18 Kyoritsu Seiyaku Corporation
List of Tables
1 Global Veterinary therapeutics Market Outlook, By Region (2024-2032) ($MN)
2 Global Veterinary therapeutics Market Outlook, By Product (2024-2032) ($MN)
3 Global Veterinary therapeutics Market Outlook, By Veterinary Drugs (2024-2032) ($MN)
4 Global Veterinary therapeutics Market Outlook, By Anti-infectives (2024-2032) ($MN)
5 Global Veterinary therapeutics Market Outlook, By Anti-inflammatory (2024-2032) ($MN)
6 Global Veterinary therapeutics Market Outlook, By Parasiticides (2024-2032) ($MN)
7 Global Veterinary therapeutics Market Outlook, By Veterinary Vaccines (2024-2032) ($MN)
8 Global Veterinary therapeutics Market Outlook, By Inactivated (2024-2032) ($MN)
9 Global Veterinary therapeutics Market Outlook, By Live Attenuated (2024-2032) ($MN)
10 Global Veterinary therapeutics Market Outlook, By Recombinant (2024-2032) ($MN)
11 Global Veterinary therapeutics Market Outlook, By Medicated Feed Additives (2024-2032) ($MN)
12 Global Veterinary therapeutics Market Outlook, By Antimicrobials (2024-2032) ($MN)
13 Global Veterinary therapeutics Market Outlook, By Anticoccidials (2024-2032) ($MN)
14 Global Veterinary therapeutics Market Outlook, By Antiparasitics (2024-2032) ($MN)
15 Global Veterinary therapeutics Market Outlook, By Animal Type (2024-2032) ($MN)
16 Global Veterinary therapeutics Market Outlook, By Companion Animals (2024-2032) ($MN)
17 Global Veterinary therapeutics Market Outlook, By Dogs (2024-2032) ($MN)
18 Global Veterinary therapeutics Market Outlook, By Horses (2024-2032) ($MN)
19 Global Veterinary therapeutics Market Outlook, By Cats (2024-2032) ($MN)
20 Global Veterinary therapeutics Market Outlook, By Livestock Animals (2024-2032) ($MN)
21 Global Veterinary therapeutics Market Outlook, By Cattle (2024-2032) ($MN)
22 Global Veterinary therapeutics Market Outlook, By Sheep & Goats (2024-2032) ($MN)
23 Global Veterinary therapeutics Market Outlook, By Poultry (2024-2032) ($MN)
24 Global Veterinary therapeutics Market Outlook, By Swine (2024-2032) ($MN)
25 Global Veterinary therapeutics Market Outlook, By Route of Administration (2024-2032) ($MN)
26 Global Veterinary therapeutics Market Outlook, By Oral (2024-2032) ($MN)
27 Global Veterinary therapeutics Market Outlook, By Parenteral (2024-2032) ($MN)
28 Global Veterinary therapeutics Market Outlook, By Topical (2024-2032) ($MN)
29 Global Veterinary therapeutics Market Outlook, By Aerosol (2024-2032) ($MN)
30 Global Veterinary therapeutics Market Outlook, By Distribution Channel (2024-2032) ($MN)
31 Global Veterinary therapeutics Market Outlook, By Veterinary Hospitals & Clinics (2024-2032) ($MN)
32 Global Veterinary therapeutics Market Outlook, By Feed Stores (2024-2032) ($MN)
33 Global Veterinary therapeutics Market Outlook, By Pharmacies (2024-2032) ($MN)
34 Global Veterinary therapeutics Market Outlook, By Online Stores (2024-2032) ($MN)
35 Global Veterinary therapeutics Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
